This document summarizes data from studies comparing percutaneous coronary intervention (PCI) using drug-eluting stents to coronary artery bypass grafting (CABG) for treating left main coronary artery disease. Some key findings from meta-analyses of randomized trials presented are that 1-year rates of death and myocardial infarction were similar for PCI and CABG, while 1-year rates of major adverse cardiac and cerebrovascular events (MACCE) were also similar. Subgroup analyses found the risk of MACCE was lower for PCI compared to CABG in patients with less complex coronary artery disease involvement. The document concludes that based on these studies, guidelines recommending CABG over PCI for left main disease should be revised to provide a